Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,423 | 522 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,619 | 83 | $0 (2024) |
| Novo Nordisk Inc | $1,176 | 73 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $804.32 | 47 | $0 (2024) |
| ABBVIE INC. | $591.05 | 40 | $0 (2024) |
| Amgen Inc. | $494.34 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $435.35 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $417.69 | 29 | $0 (2024) |
| Lilly USA, LLC | $386.27 | 26 | $0 (2024) |
| PFIZER INC. | $241.43 | 19 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $238.25 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $827.71 | 48 | Novo Nordisk Inc ($217.81) |
| 2023 | $981.11 | 60 | ABBVIE INC. ($206.03) |
| 2022 | $1,046 | 72 | ABBVIE INC. ($184.66) |
| 2021 | $1,107 | 71 | Novo Nordisk Inc ($172.16) |
| 2020 | $1,080 | 63 | Novo Nordisk Inc ($266.99) |
| 2019 | $1,225 | 78 | AstraZeneca Pharmaceuticals LP ($336.81) |
| 2018 | $1,358 | 71 | AstraZeneca Pharmaceuticals LP ($488.57) |
| 2017 | $798.19 | 59 | AstraZeneca Pharmaceuticals LP ($146.76) |
All Payment Transactions
522 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Durable Pump | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Bone Health | ||||||
| 10/16/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Hematology | ||||||
| 10/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: DIABETES | ||||||
| 08/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Bone Health | ||||||
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | Abbott Laboratories | IMMUNALYSIS CORPORATION (Device) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Rapid Diagnostics | ||||||
| 07/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: DIABETES | ||||||
| 07/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,155 | 2,313 | $439,860 | $92,784 |
| 2022 | 28 | 1,295 | 2,603 | $518,805 | $95,082 |
| 2021 | 39 | 1,634 | 3,248 | $636,235 | $107,179 |
| 2020 | 36 | 2,187 | 4,815 | $989,554 | $160,875 |
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 501 | $150,300 | $40,766 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 114 | 114 | $22,800 | $13,975 | 61.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 147 | $29,400 | $9,067 | 30.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 23 | $6,900 | $3,578 | 51.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 24 | 34 | $5,100 | $2,960 | 58.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 51 | 241 | $24,100 | $2,906 | 12.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $3,300 | $2,374 | 71.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 225 | $45,000 | $2,215 | 4.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 86 | 86 | $21,500 | $2,093 | 9.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 65 | $3,900 | $1,880 | 48.2% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 26 | 26 | $2,700 | $1,870 | 69.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 98 | 98 | $24,500 | $1,675 | 6.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 83 | 83 | $20,750 | $1,413 | 6.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 39 | 39 | $19,500 | $1,390 | 7.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 32 | $3,200 | $1,384 | 43.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 32 | 32 | $6,400 | $864.30 | 13.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 63 | 63 | $4,725 | $620.21 | 13.1% |
| 92250 | Photography of the retina | Office | 2023 | 23 | 23 | $3,450 | $593.67 | 17.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 33 | $3,300 | $468.60 | 14.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 23 | 23 | $1,150 | $406.87 | 35.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 25 | 115 | $2,875 | $138.32 | 4.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 24 | $600.00 | $81.84 | 13.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 22 | 133 | $18,810 | $53.02 | 0.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 24 | 120 | $15,600 | $10.49 | 0.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 510 | $153,000 | $42,086 | 27.5% |
About Dr. Pranay Patel, M.D
Dr. Pranay Patel, M.D is a Internal Medicine healthcare provider based in Spartanburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194729715.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pranay Patel, M.D has received a total of $8,423 in payments from pharmaceutical and medical device companies, with $827.71 received in 2024. These payments were reported across 522 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,423).
As a Medicare-enrolled provider, Patel has provided services to 6,271 Medicare beneficiaries, totaling 12,979 services with total Medicare billing of $455,920. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Spartanburg, SC
- Active Since 06/10/2005
- Last Updated 08/09/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194729715
Products in Payments
- FARXIGA (Drug) $848.08
- Ozempic (Drug) $651.59
- JARDIANCE (Drug) $596.13
- SYMBICORT (Drug) $564.16
- Kerendia (Drug) $417.69
- VRAYLAR (Drug) $270.33
- EVENITY (Biological) $240.92
- TRELEGY ELLIPTA (Drug) $228.73
- TRULICITY (Drug) $226.43
- XIFAXAN (Drug) $224.06
- Rybelsus (Drug) $206.17
- ENTRESTO (Drug) $155.21
- UBRELVY (Drug) $140.13
- RYBELSUS (Drug) $135.57
- TOUJEO (Drug) $135.39
- QULIPTA (Drug) $132.52
- ELIQUIS (Drug) $122.34
- FASENRA (Drug) $121.95
- Dexcom G6 Transmitter (Medical Supply) $116.97
- Aimovig (Biological) $114.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Spartanburg
Dr. Vikas Dembla, M.d, M.D
Internal Medicine — Payments: $548,574
Dr. Tondre Buck, M.d, M.D
Internal Medicine — Payments: $390,444
Michael Humeniuk, Md, MD
Internal Medicine — Payments: $28,166
Suzanne Kovacs, Md, MD
Internal Medicine — Payments: $16,168
Dr. Ikenna Onyebueke, Md, MD
Internal Medicine — Payments: $13,555
Dr. Subhashini Subramaniam, Md, MD
Internal Medicine — Payments: $13,395